InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Naor Nir. Officer active across 2 companies, notably Brainstorm Cell Therapeutics INC.. Cumulatively, 4 reports have been published. History available since 19 June 2023. The latest transaction was filed on 6 January 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
4 of 4 declarations